APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Andrographolide Tablets

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Andrographolide Tablets Market Analysis and Forecast 2026-2032

26 December 2025199 pages

Choose your research edition.

Industry ResearchAndrographolide Tablets Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Andrographolide Tablets Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Andrographolide Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Andrographolide Tablets Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Andrographolide Tablets Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Andrographolide Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Andrographolide Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Andrographolide Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Andrographolide Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Andrographolide Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Andrographolide Tablets include Guangdong Wannianqing Pharmaceutical Co., Ltd., Sinopharm Group Yibin Pharmaceutical Co., Ltd., Hainan Huipson Pharmaceutical Biotechnology Co., Ltd., Henan Furentang Pharmaceutical Co., Ltd., Hubei Keyi Pharmaceutical Co., Ltd., Jiangxi Qingfeng Pharmaceutical Co., Ltd., Quanzhou Zhongqiao Pharmaceutical Co., Ltd., Wuxi Jiyushanwei Pharmaceutical Co., Ltd. and Chongqing Kerui Pharmaceutical (Group) Co., Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Andrographolide Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Andrographolide Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Andrographolide Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Andrographolide Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Andrographolide Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Andrographolide Tablets sales, projected growth trends, production technology, application and end-user industry.

Andrographolide Tablets Segment by Company

Guangdong Wannianqing Pharmaceutical Co., Ltd.

Sinopharm Group Yibin Pharmaceutical Co., Ltd.

Hainan Huipson Pharmaceutical Biotechnology Co., Ltd.

Henan Furentang Pharmaceutical Co., Ltd.

Hubei Keyi Pharmaceutical Co., Ltd.

Jiangxi Qingfeng Pharmaceutical Co., Ltd.

Quanzhou Zhongqiao Pharmaceutical Co., Ltd.

Wuxi Jiyushanwei Pharmaceutical Co., Ltd.

Chongqing Kerui Pharmaceutical (Group) Co., Ltd.

Andrographolide Tablets Segment by Type

Dispersible Tablets

Conventional Tablets

Andrographolide Tablets Segment by Application

Hospital

Clinic

Other

Andrographolide Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Andrographolide Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Andrographolide Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Andrographolide Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Andrographolide Tablets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Andrographolide Tablets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Andrographolide Tablets sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Andrographolide Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Dispersible Tablets Major Manufacturers Table 3. Conventional Tablets Major Manufacturers Table 4. Global Andrographolide Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Other Major Manufacturers Table 8. Andrographolide Tablets Industry Trends Table 9. Andrographolide Tablets Industry Drivers Table 10. Andrographolide Tablets Industry Opportunities and Challenges Table 11. Andrographolide Tablets Industry Restraints Table 12. Global Andrographolide Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Andrographolide Tablets Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Andrographolide Tablets Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Andrographolide Tablets Revenue Market Share by Region (2021-2026) Table 16. Global Andrographolide Tablets Revenue Market Share by Region (2027-2032) Table 17. Global Andrographolide Tablets Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Andrographolide Tablets Sales by Region (2021-2026) & (K Units) Table 19. Global Andrographolide Tablets Sales by Region (2027-2032) & (K Units) Table 20. Global Andrographolide Tablets Sales Market Share by Region (2021-2026) Table 21. Global Andrographolide Tablets Sales Market Share by Region (2027-2032) Table 22. Global Andrographolide Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Andrographolide Tablets Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Andrographolide Tablets Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Andrographolide Tablets Sales Market Share by Manufacturers (2021-2026) Table 26. Global Andrographolide Tablets Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Andrographolide Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Andrographolide Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Andrographolide Tablets Manufacturers, Product Type & Application Table 30. Global Andrographolide Tablets Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Andrographolide Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Andrographolide Tablets Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Andrographolide Tablets Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Andrographolide Tablets Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Andrographolide Tablets Revenue Market Share by Type (2021-2026) Table 37. Global Andrographolide Tablets Revenue Market Share by Type (2027-2032) Table 38. Global Andrographolide Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Andrographolide Tablets Sales by Type (2021-2026) & (K Units) Table 40. Global Andrographolide Tablets Sales by Type (2027-2032) & (K Units) Table 41. Global Andrographolide Tablets Sales Market Share by Type (2021-2026) Table 42. Global Andrographolide Tablets Sales Market Share by Type (2027-2032) Table 43. Global Andrographolide Tablets Price by Type (2021-2026) & (US$/Unit) Table 44. Global Andrographolide Tablets Price by Type (2027-2032) & (US$/Unit) Table 45. Global Andrographolide Tablets Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Andrographolide Tablets Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Andrographolide Tablets Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Andrographolide Tablets Revenue Market Share by Application (2021-2026) Table 49. Global Andrographolide Tablets Revenue Market Share by Application (2027-2032) Table 50. Global Andrographolide Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Andrographolide Tablets Sales by Application (2021-2026) & (K Units) Table 52. Global Andrographolide Tablets Sales by Application (2027-2032) & (K Units) Table 53. Global Andrographolide Tablets Sales Market Share by Application (2021-2026) Table 54. Global Andrographolide Tablets Sales Market Share by Application (2027-2032) Table 55. Global Andrographolide Tablets Price by Application (2021-2026) & (US$/Unit) Table 56. Global Andrographolide Tablets Price by Application (2027-2032) & (US$/Unit) Table 57. Guangdong Wannianqing Pharmaceutical Co., Ltd. Company Information Table 58. Guangdong Wannianqing Pharmaceutical Co., Ltd. Business Overview Table 59. Guangdong Wannianqing Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Guangdong Wannianqing Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 61. Guangdong Wannianqing Pharmaceutical Co., Ltd. Recent Development Table 62. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Company Information Table 63. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Business Overview Table 64. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 66. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Recent Development Table 67. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Company Information Table 68. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Business Overview Table 69. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Andrographolide Tablets Product Portfolio Table 71. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Recent Development Table 72. Henan Furentang Pharmaceutical Co., Ltd. Company Information Table 73. Henan Furentang Pharmaceutical Co., Ltd. Business Overview Table 74. Henan Furentang Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Henan Furentang Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 76. Henan Furentang Pharmaceutical Co., Ltd. Recent Development Table 77. Hubei Keyi Pharmaceutical Co., Ltd. Company Information Table 78. Hubei Keyi Pharmaceutical Co., Ltd. Business Overview Table 79. Hubei Keyi Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Hubei Keyi Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 81. Hubei Keyi Pharmaceutical Co., Ltd. Recent Development Table 82. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Company Information Table 83. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Business Overview Table 84. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 86. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Recent Development Table 87. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Company Information Table 88. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Business Overview Table 89. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 91. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Recent Development Table 92. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Company Information Table 93. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Business Overview Table 94. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 96. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Recent Development Table 97. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Company Information Table 98. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Business Overview Table 99. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Andrographolide Tablets Product Portfolio Table 101. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Recent Development Table 102. North America Andrographolide Tablets Revenue by Type (2021-2026) & (US$ Million) Table 103. North America Andrographolide Tablets Revenue by Type (2027-2032) & (US$ Million) Table 104. North America Andrographolide Tablets Sales by Type (2021-2026) & (K Units) Table 105. North America Andrographolide Tablets Sales by Type (2027-2032) & (K Units) Table 106. North America Andrographolide Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 107. North America Andrographolide Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 108. North America Andrographolide Tablets Revenue by Application (2021-2026) & (US$ Million) Table 109. North America Andrographolide Tablets Revenue by Application (2027-2032) & (US$ Million) Table 110. North America Andrographolide Tablets Sales by Application (2021-2026) & (K Units) Table 111. North America Andrographolide Tablets Sales by Application (2027-2032) & (K Units) Table 112. North America Andrographolide Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 113. North America Andrographolide Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 114. North America Andrographolide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. North America Andrographolide Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 116. North America Andrographolide Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 117. North America Andrographolide Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 118. North America Andrographolide Tablets Sales by Country (2021-2026) & (K Units) Table 119. North America Andrographolide Tablets Sales by Country (2027-2032) & (K Units) Table 120. North America Andrographolide Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 121. North America Andrographolide Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 122. United States Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Table 123. Canada Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Table 124. Mexico Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Table 125. Europe Andrographolide Tablets Revenue by Type (2021-2026) & (US$ Million) Table 126. Europe Andrographolide Tablets Revenue by Type (2027-2032) & (US$ Million) Table 127. Europe Andrographolide Tablets Sales by Type (2021-2026) & (K Units) Table 128. Europe Andrographolide Tablets Sales by Type (2027-2032) & (K Units) Table 129. Europe Andrographolide Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 130. Europe Andrographolide Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 131. Europe Andrographolide Tablets Revenue by Application (2021-2026) & (US$ Million) Table 132. Europe Andrographolide Tablets Revenue by Application (2027-2032) & (US$ Million) Table 133. Europe Andrographolide Tablets Sales by Application (2021-2026) & (K Units) Table 134. Europe Andrographolide Tablets Sales by Application (2027-2032) & (K Units) Table 135. Europe Andrographolide Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 136. Europe Andrographolide Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 137. Europe Andrographolide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. Europe Andrographolide Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 139. Europe Andrographolide Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 140. Europe Andrographolide Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 141. Europe Andrographolide Tablets Sales by Country (2021-2026) & (K Units) Table 142. Europe Andrographolide Tablets Sales by Country (2027-2032) & (K Units) Table 143. Europe Andrographolide Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 144. Europe Andrographolide Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 145. Germany Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Table 146. France Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Table 147. U.K. Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Table 148. Italy Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Table 149. Russia Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Table 150. Spain Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Table 151. Netherlands Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Table 152. Switzerland Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Table 153. Sweden Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Table 154. Poland Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Table 155. China Andrographolide Tablets Revenue by Type (2021-2026) & (US$ Million) Table 156. China Andrographolide Tablets Revenue by Type (2027-2032) & (US$ Million) Table 157. China Andrographolide Tablets Sales by Type (2021-2026) & (K Units) Table 158. China Andrographolide Tablets Sales by Type (2027-2032) & (K Units) Table 159. China Andrographolide Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 160. China Andrographolide Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 161. China Andrographolide Tablets Revenue by Application (2021-2026) & (US$ Million) Table 162. China Andrographolide Tablets Revenue by Application (2027-2032) & (US$ Million) Table 163. China Andrographolide Tablets Sales by Application (2021-2026) & (K Units) Table 164. China Andrographolide Tablets Sales by Application (2027-2032) & (K Units) Table 165. China Andrographolide Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 166. China Andrographolide Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 167. Asia Andrographolide Tablets Revenue by Type (2021-2026) & (US$ Million) Table 168. Asia Andrographolide Tablets Revenue by Type (2027-2032) & (US$ Million) Table 169. Asia Andrographolide Tablets Sales by Type (2021-2026) & (K Units) Table 170. Asia Andrographolide Tablets Sales by Type (2027-2032) & (K Units) Table 171. Asia Andrographolide Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 172. Asia Andrographolide Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 173. Asia Andrographolide Tablets Revenue by Application (2021-2026) & (US$ Million) Table 174. Asia Andrographolide Tablets Revenue by Application (2027-2032) & (US$ Million) Table 175. Asia Andrographolide Tablets Sales by Application (2021-2026) & (K Units) Table 176. Asia Andrographolide Tablets Sales by Application (2027-2032) & (K Units) Table 177. Asia Andrographolide Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 178. Asia Andrographolide Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 179. Asia Andrographolide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 180. Asia Andrographolide Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 181. Asia Andrographolide Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 182. Asia Andrographolide Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 183. Asia Andrographolide Tablets Sales by Country (2021-2026) & (K Units) Table 184. Asia Andrographolide Tablets Sales by Country (2027-2032) & (K Units) Table 185. Asia Andrographolide Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 186. Asia Andrographolide Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 187. Japan Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Table 188. South Korea Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Table 189. India Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Table 190. Australia Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Table 191. Taiwan Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Table 192. Southeast Asia Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Table 193. SAMEA Andrographolide Tablets Revenue by Type (2021-2026) & (US$ Million) Table 194. SAMEA Andrographolide Tablets Revenue by Type (2027-2032) & (US$ Million) Table 195. SAMEA Andrographolide Tablets Sales by Type (2021-2026) & (K Units) Table 196. SAMEA Andrographolide Tablets Sales by Type (2027-2032) & (K Units) Table 197. SAMEA Andrographolide Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 198. SAMEA Andrographolide Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 199. SAMEA Andrographolide Tablets Revenue by Application (2021-2026) & (US$ Million) Table 200. SAMEA Andrographolide Tablets Revenue by Application (2027-2032) & (US$ Million) Table 201. SAMEA Andrographolide Tablets Sales by Application (2021-2026) & (K Units) Table 202. SAMEA Andrographolide Tablets Sales by Application (2027-2032) & (K Units) Table 203. SAMEA Andrographolide Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 204. SAMEA Andrographolide Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 205. SAMEA Andrographolide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 206. SAMEA Andrographolide Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 207. SAMEA Andrographolide Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 208. SAMEA Andrographolide Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 209. SAMEA Andrographolide Tablets Sales by Country (2021-2026) & (K Units) Table 210. SAMEA Andrographolide Tablets Sales by Country (2027-2032) & (K Units) Table 211. SAMEA Andrographolide Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 212. SAMEA Andrographolide Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 213. Brazil Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Table 214. Argentina Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Table 215. Chile Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Table 216. Colombia Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Table 217. Peru Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Table 218. Saudi Arabia Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Table 219. Israel Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Table 220. UAE Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Table 221. Turkey Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Table 222. Iran Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Table 223. Egypt Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Table 224. Key Raw Materials Table 225. Raw Materials Key Suppliers Table 226. Andrographolide Tablets Distributors List Table 227. Andrographolide Tablets Customers List Table 228. Research Programs/Design for This Report Table 229. Authors List of This Report Table 230. Secondary Sources Table 231. Primary Sources List of Figures Figure 1. Andrographolide Tablets Image Figure 2. Global Andrographolide Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Andrographolide Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 4. Dispersible Tablets Image Figure 5. Conventional Tablets Image Figure 6. Global Andrographolide Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Andrographolide Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Other Image Figure 11. Global Andrographolide Tablets Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Figure 13. Global Andrographolide Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Andrographolide Tablets Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Andrographolide Tablets Revenue Market Share by Region (2021-2032) Figure 16. Global Andrographolide Tablets Sales (2021-2032) & (K Units) Figure 17. Global Andrographolide Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Andrographolide Tablets Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Andrographolide Tablets Sales YoY (2021-2032) & (K Units) Figure 20. Europe Andrographolide Tablets Sales YoY (2021-2032) & (K Units) Figure 21. China Andrographolide Tablets Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Andrographolide Tablets Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Andrographolide Tablets Sales YoY (2021-2032) & (K Units) Figure 24. Global Andrographolide Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Andrographolide Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Andrographolide Tablets Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Andrographolide Tablets Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Andrographolide Tablets Revenue Market Share by Type (2021-2032) Figure 30. Global Andrographolide Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Andrographolide Tablets Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Andrographolide Tablets Sales Market Share by Type (2021-2032) Figure 33. Global Andrographolide Tablets Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Andrographolide Tablets Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Andrographolide Tablets Revenue Market Share by Application (2021-2032) Figure 36. Global Andrographolide Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Andrographolide Tablets Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Andrographolide Tablets Sales Market Share by Application (2021-2032) Figure 39. North America Andrographolide Tablets Revenue Share by Type (2021-2032) Figure 40. North America Andrographolide Tablets Sales Share by Type (2021-2032) Figure 41. North America Andrographolide Tablets Revenue Share by Application (2021-2032) Figure 42. North America Andrographolide Tablets Sales Share by Application (2021-2032) Figure 43. North America Andrographolide Tablets Revenue Share by Country (2021-2032) Figure 44. North America Andrographolide Tablets Sales Share by Country (2021-2032) Figure 45. Europe Andrographolide Tablets Revenue Share by Type (2021-2032) Figure 46. Europe Andrographolide Tablets Sales Share by Type (2021-2032) Figure 47. Europe Andrographolide Tablets Revenue Share by Application (2021-2032) Figure 48. Europe Andrographolide Tablets Sales Share by Application (2021-2032) Figure 49. Europe Andrographolide Tablets Revenue Share by Country (2021-2032) Figure 50. Europe Andrographolide Tablets Sales Share by Country (2021-2032) Figure 51. China Andrographolide Tablets Revenue Share by Type (2021-2032) Figure 52. China Andrographolide Tablets Sales Share by Type (2021-2032) Figure 53. China Andrographolide Tablets Revenue Share by Application (2021-2032) Figure 54. China Andrographolide Tablets Sales Share by Application (2021-2032) Figure 55. Asia Andrographolide Tablets Revenue Share by Type (2021-2032) Figure 56. Asia Andrographolide Tablets Sales Share by Type (2021-2032) Figure 57. Asia Andrographolide Tablets Revenue Share by Application (2021-2032) Figure 58. Asia Andrographolide Tablets Sales Share by Application (2021-2032) Figure 59. Asia Andrographolide Tablets Revenue Share by Country (2021-2032) Figure 60. Asia Andrographolide Tablets Sales Share by Country (2021-2032) Figure 61. SAMEA Andrographolide Tablets Revenue Share by Type (2021-2032) Figure 62. SAMEA Andrographolide Tablets Sales Share by Type (2021-2032) Figure 63. SAMEA Andrographolide Tablets Revenue Share by Application (2021-2032) Figure 64. SAMEA Andrographolide Tablets Sales Share by Application (2021-2032) Figure 65. SAMEA Andrographolide Tablets Revenue Share by Country (2021-2032) Figure 66. SAMEA Andrographolide Tablets Sales Share by Country (2021-2032) Figure 67. Andrographolide Tablets Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Andrographolide Tablets Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Dispersible Tablets
  • Conventional Tablets
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Guangdong Wannianqing Pharmaceutical Co., Ltd.
  • Sinopharm Group Yibin Pharmaceutical Co., Ltd.
  • Hainan Huipson Pharmaceutical Biotechnology Co., Ltd.
  • Henan Furentang Pharmaceutical Co., Ltd.
  • Hubei Keyi Pharmaceutical Co., Ltd.
  • Jiangxi Qingfeng Pharmaceutical Co., Ltd.
  • Quanzhou Zhongqiao Pharmaceutical Co., Ltd.
  • Wuxi Jiyushanwei Pharmaceutical Co., Ltd.
  • Chongqing Kerui Pharmaceutical (Group) Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Andrographolide Tablets Market by Type
  3. 1.2.1 Global Andrographolide Tablets Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Dispersible Tablets
  5. 1.2.3 Conventional Tablets
  6. 1.3 Andrographolide Tablets Market by Application
  7. 1.3.1 Global Andrographolide Tablets Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Andrographolide Tablets Market Dynamics
  1. 2.1 Andrographolide Tablets Industry Trends
  2. 2.2 Andrographolide Tablets Industry Drivers
  3. 2.3 Andrographolide Tablets Industry Opportunities and Challenges
  4. 2.4 Andrographolide Tablets Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Andrographolide Tablets Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Andrographolide Tablets Revenue by Region
  3. 3.2.1 Global Andrographolide Tablets Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Andrographolide Tablets Revenue by Region (2021-2026)
  5. 3.2.3 Global Andrographolide Tablets Revenue by Region (2027-2032)
  6. 3.2.4 Global Andrographolide Tablets Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Andrographolide Tablets Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Andrographolide Tablets Sales by Region
  9. 3.4.1 Global Andrographolide Tablets Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Andrographolide Tablets Sales by Region (2021-2026)
  11. 3.4.3 Global Andrographolide Tablets Sales by Region (2027-2032)
  12. 3.4.4 Global Andrographolide Tablets Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Andrographolide Tablets Revenue by Manufacturers
  2. 4.1.1 Global Andrographolide Tablets Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Andrographolide Tablets Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Andrographolide Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Andrographolide Tablets Sales by Manufacturers
  6. 4.2.1 Global Andrographolide Tablets Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Andrographolide Tablets Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Andrographolide Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Andrographolide Tablets Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Andrographolide Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Andrographolide Tablets Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Andrographolide Tablets Manufacturers, Product Type & Application
  13. 4.7 Global Andrographolide Tablets Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Andrographolide Tablets Market CR5 and HHI
  16. 4.8.2 2025 Andrographolide Tablets Tier 1, Tier 2, and Tier 3
5 Andrographolide Tablets Market by Type
  1. 5.1 Global Andrographolide Tablets Revenue by Type
  2. 5.1.1 Global Andrographolide Tablets Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Andrographolide Tablets Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Andrographolide Tablets Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Andrographolide Tablets Sales by Type
  6. 5.2.1 Global Andrographolide Tablets Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Andrographolide Tablets Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Andrographolide Tablets Sales Market Share by Type (2021-2032)
  9. 5.3 Global Andrographolide Tablets Price by Type
6 Andrographolide Tablets Market by Application
  1. 6.1 Global Andrographolide Tablets Revenue by Application
  2. 6.1.1 Global Andrographolide Tablets Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Andrographolide Tablets Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Andrographolide Tablets Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Andrographolide Tablets Sales by Application
  6. 6.2.1 Global Andrographolide Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Andrographolide Tablets Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Andrographolide Tablets Sales Market Share by Application (2021-2032)
  9. 6.3 Global Andrographolide Tablets Price by Application
7 Company Profiles
  1. 7.1 Guangdong Wannianqing Pharmaceutical Co., Ltd.
  2. 7.1.1 Guangdong Wannianqing Pharmaceutical Co., Ltd. Company Information
  3. 7.1.2 Guangdong Wannianqing Pharmaceutical Co., Ltd. Business Overview
  4. 7.1.3 Guangdong Wannianqing Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Guangdong Wannianqing Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  6. 7.1.5 Guangdong Wannianqing Pharmaceutical Co., Ltd. Recent Developments
  7. 7.2 Sinopharm Group Yibin Pharmaceutical Co., Ltd.
  8. 7.2.1 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Company Information
  9. 7.2.2 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Business Overview
  10. 7.2.3 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  12. 7.2.5 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Recent Developments
  13. 7.3 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd.
  14. 7.3.1 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Company Information
  15. 7.3.2 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Business Overview
  16. 7.3.3 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Andrographolide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Andrographolide Tablets Product Portfolio
  18. 7.3.5 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Recent Developments
  19. 7.4 Henan Furentang Pharmaceutical Co., Ltd.
  20. 7.4.1 Henan Furentang Pharmaceutical Co., Ltd. Company Information
  21. 7.4.2 Henan Furentang Pharmaceutical Co., Ltd. Business Overview
  22. 7.4.3 Henan Furentang Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Henan Furentang Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  24. 7.4.5 Henan Furentang Pharmaceutical Co., Ltd. Recent Developments
  25. 7.5 Hubei Keyi Pharmaceutical Co., Ltd.
  26. 7.5.1 Hubei Keyi Pharmaceutical Co., Ltd. Company Information
  27. 7.5.2 Hubei Keyi Pharmaceutical Co., Ltd. Business Overview
  28. 7.5.3 Hubei Keyi Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Hubei Keyi Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  30. 7.5.5 Hubei Keyi Pharmaceutical Co., Ltd. Recent Developments
  31. 7.6 Jiangxi Qingfeng Pharmaceutical Co., Ltd.
  32. 7.6.1 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Company Information
  33. 7.6.2 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Business Overview
  34. 7.6.3 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  36. 7.6.5 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Recent Developments
  37. 7.7 Quanzhou Zhongqiao Pharmaceutical Co., Ltd.
  38. 7.7.1 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Company Information
  39. 7.7.2 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Business Overview
  40. 7.7.3 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  42. 7.7.5 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Recent Developments
  43. 7.8 Wuxi Jiyushanwei Pharmaceutical Co., Ltd.
  44. 7.8.1 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Company Information
  45. 7.8.2 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Business Overview
  46. 7.8.3 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  48. 7.8.5 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Recent Developments
  49. 7.9 Chongqing Kerui Pharmaceutical (Group) Co., Ltd.
  50. 7.9.1 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Company Information
  51. 7.9.2 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Business Overview
  52. 7.9.3 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Andrographolide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Andrographolide Tablets Product Portfolio
  54. 7.9.5 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Recent Developments
8 North America
  1. 8.1 North America Andrographolide Tablets Market Size by Type
  2. 8.1.1 North America Andrographolide Tablets Revenue by Type (2021-2032)
  3. 8.1.2 North America Andrographolide Tablets Sales by Type (2021-2032)
  4. 8.1.3 North America Andrographolide Tablets Price by Type (2021-2032)
  5. 8.2 North America Andrographolide Tablets Market Size by Application
  6. 8.2.1 North America Andrographolide Tablets Revenue by Application (2021-2032)
  7. 8.2.2 North America Andrographolide Tablets Sales by Application (2021-2032)
  8. 8.2.3 North America Andrographolide Tablets Price by Application (2021-2032)
  9. 8.3 North America Andrographolide Tablets Market Size by Country
  10. 8.3.1 North America Andrographolide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Andrographolide Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Andrographolide Tablets Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Andrographolide Tablets Market Size by Type
  2. 9.1.1 Europe Andrographolide Tablets Revenue by Type (2021-2032)
  3. 9.1.2 Europe Andrographolide Tablets Sales by Type (2021-2032)
  4. 9.1.3 Europe Andrographolide Tablets Price by Type (2021-2032)
  5. 9.2 Europe Andrographolide Tablets Market Size by Application
  6. 9.2.1 Europe Andrographolide Tablets Revenue by Application (2021-2032)
  7. 9.2.2 Europe Andrographolide Tablets Sales by Application (2021-2032)
  8. 9.2.3 Europe Andrographolide Tablets Price by Application (2021-2032)
  9. 9.3 Europe Andrographolide Tablets Market Size by Country
  10. 9.3.1 Europe Andrographolide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Andrographolide Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Andrographolide Tablets Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Andrographolide Tablets Market Size by Type
  2. 10.1.1 China Andrographolide Tablets Revenue by Type (2021-2032)
  3. 10.1.2 China Andrographolide Tablets Sales by Type (2021-2032)
  4. 10.1.3 China Andrographolide Tablets Price by Type (2021-2032)
  5. 10.2 China Andrographolide Tablets Market Size by Application
  6. 10.2.1 China Andrographolide Tablets Revenue by Application (2021-2032)
  7. 10.2.2 China Andrographolide Tablets Sales by Application (2021-2032)
  8. 10.2.3 China Andrographolide Tablets Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Andrographolide Tablets Market Size by Type
  2. 11.1.1 Asia Andrographolide Tablets Revenue by Type (2021-2032)
  3. 11.1.2 Asia Andrographolide Tablets Sales by Type (2021-2032)
  4. 11.1.3 Asia Andrographolide Tablets Price by Type (2021-2032)
  5. 11.2 Asia Andrographolide Tablets Market Size by Application
  6. 11.2.1 Asia Andrographolide Tablets Revenue by Application (2021-2032)
  7. 11.2.2 Asia Andrographolide Tablets Sales by Application (2021-2032)
  8. 11.2.3 Asia Andrographolide Tablets Price by Application (2021-2032)
  9. 11.3 Asia Andrographolide Tablets Market Size by Country
  10. 11.3.1 Asia Andrographolide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Andrographolide Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Andrographolide Tablets Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Andrographolide Tablets Market Size by Type
  2. 12.1.1 SAMEA Andrographolide Tablets Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Andrographolide Tablets Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Andrographolide Tablets Price by Type (2021-2032)
  5. 12.2 SAMEA Andrographolide Tablets Market Size by Application
  6. 12.2.1 SAMEA Andrographolide Tablets Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Andrographolide Tablets Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Andrographolide Tablets Price by Application (2021-2032)
  9. 12.3 SAMEA Andrographolide Tablets Market Size by Country
  10. 12.3.1 SAMEA Andrographolide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Andrographolide Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Andrographolide Tablets Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Andrographolide Tablets Value Chain Analysis
  2. 13.1.1 Andrographolide Tablets Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Andrographolide Tablets Production Mode & Process
  6. 13.2 Andrographolide Tablets Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Andrographolide Tablets Distributors
  9. 13.2.3 Andrographolide Tablets Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst